- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05014256
System Interventions to Achieve Early and Equitable Transplants (STEPS) Study
January 27, 2026 updated by: Wake Forest University Health Sciences
This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease.
A study focused on equality and patient needs (called 'STEPS') will 1) create a program to identify people who may need a kidney transplant ('STEPS Surveillance') and find people in health systems who may be able to receive kidney transplants early in their care and (2) study how well the 'STEPS Outreach' program works (comprised of transplant social workers and transplant coordinators who focus on equality and patient needs) compared to usual care to improve access to kidney transplants among Black and non-Black individuals as well as to improve access to transplants for everyone.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27101
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ability to provide oral informed consent
- Male or female, aged 18 to <=75 years
- Presence of CKD (2 eGFRs <60, 90 days apart) and at least 1 of the following: most recent eGFR less than 30 or KFRE greater than 10%
- English speaking with adequate ability to hear and understand questions over the phone
- Willing to comply with all study procedures and be available for the duration of the study
Exclusion Criteria:
- Male or female, aged <18 or > 75 years
- Non-English speaking
- Lack of ability to hear and comprehend verbal communication.
- Patients on dialysis
- Deceased
- Hospice/palliative care
- Prior kidney transplant
- Currently waitlisted at any transplant center
- Self-reported terminal illness or receipt of hospice services
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: STEPS Health System Surveillance and Outreach intervention
|
STEPS Transplant Social Worker Education and Outreach, STEPS Transplant Coordinator Outreach
|
|
No Intervention: Usual Kidney Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health system reported completion of transplant evaluation
Time Frame: 18 months
|
Number of patients that said "yes" to the completion of transplant evaluation as reported in health system EHR and Administrative reports
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health system reported initiation of transplant evaluation
Time Frame: 18 months
|
Number of patients that said "yes" to the initiation of transplant evaluation as reported in health system EHR and Administrative reports
|
18 months
|
|
Live donor inquires to transplant center
Time Frame: 6 months, 12 months, 18 months
|
the number of participants that made an inquiry to the transplant center related to live donors as reported in EHR or from questionnaire
|
6 months, 12 months, 18 months
|
|
Live kidney donor transplants
Time Frame: 6 months, 12 months, 18 months
|
The number of participants that completed their live kidney donor transplant as reported by the EHR or questionnaire
|
6 months, 12 months, 18 months
|
|
Placement on deceased kidney donor waitlist
Time Frame: 6 months, 12 months, 18 months
|
The number of patients that have been placed on the deceased kidney donor waitlist as reported in the EHR or UNOS
|
6 months, 12 months, 18 months
|
|
Deceased kidney donor transplants
Time Frame: 6 months, 12 months, 18 months
|
The number of patients that received a deceased kidney donor transplant as reported in EHR or USRDS
|
6 months, 12 months, 18 months
|
|
Patient reported physician discussions
Time Frame: baseline, 6 months, 12 months, 18 months
|
number of times patient talked to physician regarding kidney transplant measured by patient report in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported family discussions
Time Frame: baseline, 6 months, 12 months, 18 months
|
number of times patient talked to family regarding kidney transplant measured by patient reported in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported initiation of transplant evaluation
Time Frame: baseline, 6 months, 12 months, 18 months
|
Number of patients that said "yes" to the initiation of transplant evaluation measured by patient report in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported completion of transplant evaluation
Time Frame: baseline, 6 months, 12 months, 18 months
|
Number of patients that said "yes" to the completion of transplant evaluation measured by patient report in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported identification of a living donor
Time Frame: baseline, 6 months, 12 months, 18 months
|
Number of patients that said "yes" to the identification of a living donor measured by patient report in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported kidney transplant knowledge
Time Frame: baseline, 6 months, 12 months, 18 months
|
Number of questions patients correctly answer measured by patient report in questionnaire
|
baseline, 6 months, 12 months, 18 months
|
|
Patient reported empowerment
Time Frame: baseline, 6 months, 12 months, 18 months
|
Calculation of scaled questions from the adapted DES-SF form using a range of 1-5 for each question, with 5 being the best outcome, measured by patient report in questionnaire.
|
baseline, 6 months, 12 months, 18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ebony Boulware, M.D., Wake Forest University Health Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 2, 2022
Primary Completion (Actual)
December 31, 2025
Study Completion (Actual)
December 31, 2025
Study Registration Dates
First Submitted
August 13, 2021
First Submitted That Met QC Criteria
August 13, 2021
First Posted (Actual)
August 20, 2021
Study Record Updates
Last Update Posted (Actual)
January 29, 2026
Last Update Submitted That Met QC Criteria
January 27, 2026
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pathologic Processes
- Male Urogenital Diseases
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Chronic Disease
- Disease Attributes
- Renal Insufficiency
- Pathological Conditions, Signs and Symptoms
- Renal Insufficiency, Chronic
Other Study ID Numbers
- IRB00097407
- 7U01DK127918-02 (U.S. NIH Grant/Contract)
- IHS-2020C1-19350-IC (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Benha UniversityCompletedChronic Kidney Diseases | Chronic Kidney Disease 5DEgypt
Clinical Trials on STEPS Health System Outreach intervention
-
Duke UniversityCompleted
-
University of MichiganCompletedChronic PainUnited States
-
The University of Texas Health Science Center,...Baylor College of Medicine; Duke University; Centers for Disease Control and... and other collaboratorsCompleted
-
Rush University Medical CenterUniversity of ChicagoEnrolling by invitation
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
University of British ColumbiaDalhousie University; Social Sciences and Humanities Research Council of Canada and other collaboratorsCompletedGender-based Violence | Outreach InterventionCanada
-
OCHIN, Inc.Oregon Health and Science UniversityCompletedInsurance Status/Stability
-
University of British ColumbiaSocial Sciences and Humanities Research Council of Canada; Michael Smith Foundation... and other collaboratorsCompletedGender-based Violence | Outreach InterventionCanada
-
University of British ColumbiaVancouver Foundation; Inner-City Women's Initiatives SocietyCompletedSafety | Access to Health Care | Outreach Intervention | Gender-Based Violence | Access to Social ServicesCanada